A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)

NCT00092391 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1997

Enrollment

INDUSTRY

Sponsor class

Conditions

Measles
Mumps
Rubella
Varicella

Interventions

BIOLOGICAL: Comparator: M-M-R(TM) II, measles, mumps, and rubella virus vaccine live
BIOLOGICAL: Comparator: VARIVAX(TM) Varicella Virus Vaccine Live (Oka-Merck)

Sponsor

Merck Sharp & Dohme LLC